This podcast episode explores the journey of Marc Lohrmann, the managing partner of Vesalius Biocapital Fund III, from his background as a professional tennis player to his career in venture capital. Marc's experiences as an entrepreneur and his involvement in starting several life sciences companies have shaped his unique perspective as a venture capitalist. The episode also discusses Vesalius's country agnostic approach to venture capital investments in Europe, the challenges and strategies of European venture capitalists in identifying and developing investment opportunities, the investment approach of Vesalius focused on life sciences, the complexities of investing in life sciences compared to mainstream verticals, the role of investors without a scientific background in the life sciences sector, the fundraising process for Vesalius Biocapital III, the evolution of Vesalius's investment strategy and portfolio balance, and the current state of the European VC landscape and the desired changes.
